cancer vaccines
Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial
The companies will use Personalis' ImmunoID Next technology to analyze patient response to a combination of Evaxion's EVX-01 with the immunotherapy Keytruda.
NEC OncoImmunity Acquires Vaximm's Neoantigen Vaccine Program
The firm expects to begin clinical trials of personalized cancer vaccines based on Vaximm's assets this year.
Targovax, Agenus Partner to Develop KRAS-Targeted Cancer Vaccines
Agenus will supply its immune-boosting adjuvant for use with Targovax's cancer vaccines in up to three clinical trials.
Transgene Expands Study of Vaccine in HPV16-Positive Anogenital Cancer
The Phase II trial will compare Transgene's TG4001 plus Bavencio against just Bavencio in patients with HPV16-positive anogenital cancer.
Nouscom to Evaluate Bespoke Cancer Vaccine NOUS-PEV in European Phase I Study
The personalized neoantigen-based vaccine, manufactured on a per-patient basis, will be evaluated in combination with Keytruda for melanoma and NSCLC. Â